Literature DB >> 28368249

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer.

Weigang Yan1, Yi Zhou2, Zhien Zhou2, Zhigang Ji2, Hanzhong Li2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28368249     DOI： 10.1016/S1470-2045(17)30170-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.

Authors:  Liming Liang; Wenxiang Bi; Weiwen Chen; Yani Lin; Yuanyuan Tian
Journal:  Lasers Med Sci       Date:  2018-01-06       Impact factor: 3.161

2.  A Tumor Vascular-Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia.

Authors:  Xin Luan; Ying-Yun Guan; Hai-Jun Liu; Qin Lu; Mei Zhao; Duxin Sun; Jonathan F Lovell; Peng Sun; Hong-Zhuan Chen; Chao Fang
Journal:  Adv Sci (Weinh)       Date:  2018-05-28       Impact factor: 16.806
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.